Matches in Wikidata for { <http://www.wikidata.org/entity/Q87867825> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q87867825 description "artículu científicu espublizáu en febreru de 2018" @default.
- Q87867825 description "im Februar 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q87867825 description "scientific article published on 22 February 2018" @default.
- Q87867825 description "wetenschappelijk artikel" @default.
- Q87867825 description "наукова стаття, опублікована 22 лютого 2018" @default.
- Q87867825 name "Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration" @default.
- Q87867825 name "Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration" @default.
- Q87867825 type Item @default.
- Q87867825 label "Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration" @default.
- Q87867825 label "Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration" @default.
- Q87867825 prefLabel "Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration" @default.
- Q87867825 prefLabel "Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration" @default.
- Q87867825 P1433 Q87867825-EC0DFE00-13AF-406C-B493-90297062FFCA @default.
- Q87867825 P1476 Q87867825-22DFB2B6-3AF1-49C1-B6C4-298920D15C4D @default.
- Q87867825 P2093 Q87867825-AA735EC4-CCC9-4384-8A35-4B369A10B3BD @default.
- Q87867825 P2093 Q87867825-BAA9BFE5-413E-458F-9894-8F2675EF9018 @default.
- Q87867825 P304 Q87867825-682100B1-4A7F-4065-9331-F74859BCBAC3 @default.
- Q87867825 P31 Q87867825-2979E358-4B8C-4A86-8B44-F0A7A2569688 @default.
- Q87867825 P356 Q87867825-A2B03560-CE30-417B-A508-222ECF6C4B9F @default.
- Q87867825 P433 Q87867825-DE111195-DEF3-4FE7-A41B-2A2D03DAFEAB @default.
- Q87867825 P478 Q87867825-929492AE-4165-4004-98BF-295C9159C665 @default.
- Q87867825 P50 Q87867825-ED7D4E7E-4060-4F99-AD13-0BD286A3DE36 @default.
- Q87867825 P577 Q87867825-599A0CBE-CBC8-49E0-85A4-F6F6C087C4DE @default.
- Q87867825 P698 Q87867825-431C625A-7B2E-4F0A-9DF4-582050E357AE @default.
- Q87867825 P921 Q87867825-12FF5444-DFB4-438A-AE04-0F48E9C641F3 @default.
- Q87867825 P921 Q87867825-C777362D-0E4B-44A1-A4F4-498218C79CA8 @default.
- Q87867825 P356 J.SURVOPHTHAL.2018.02.004 @default.
- Q87867825 P698 29476754 @default.
- Q87867825 P1433 Q7647088 @default.
- Q87867825 P1476 "Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration" @default.
- Q87867825 P2093 "Eric H Souied" @default.
- Q87867825 P2093 "Irmela Mantel" @default.
- Q87867825 P304 "638-645" @default.
- Q87867825 P31 Q13442814 @default.
- Q87867825 P356 "10.1016/J.SURVOPHTHAL.2018.02.004" @default.
- Q87867825 P433 "5" @default.
- Q87867825 P478 "63" @default.
- Q87867825 P50 Q87867823 @default.
- Q87867825 P577 "2018-02-22T00:00:00Z" @default.
- Q87867825 P698 "29476754" @default.
- Q87867825 P921 Q27429789 @default.
- Q87867825 P921 Q4689286 @default.